| Literature DB >> 36109765 |
Njelembo J Mbewe1,2, Mark W Rowland3, Janneke Snetselaar4, Salum Azizi5, Graham Small4, Derric D Nimmo4, Franklin W Mosha5.
Abstract
BACKGROUND: Optimising insecticide use and managing insecticide resistance are important to sustain gains against malaria using long-lasting insecticidal nets (LLINs). Restricting insecticides to where mosquitoes are most likely to make multiple contacts could reduce the quantity of insecticide needed to treat the nets. Previous studies have shown that nets partially treated with a pyrethroid insecticide had equivalent mortality compared to a fully treated net. This study compared the efficacy of: (i) whole Interceptor® G2 nets (IG2; a dual-active LLIN containing alpha-cypermethrin and chlorfenapyr), (ii) nets with roof panels made of IG2 netting, (iii) nets with side panels made of IG2 netting and (iv) whole untreated nets as test nets.Entities:
Keywords: Alphacypermethrin; Anopheles arabiensis; Chlorfenapyr; Insecticide resistance; Long-lasting insecticidal nets; Partially treated nets
Mesh:
Substances:
Year: 2022 PMID: 36109765 PMCID: PMC9479251 DOI: 10.1186/s13071-022-05454-w
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 4.047
Fig. 1Schematic diagram of different LLIN designs used in trial arms; roof-treated IG2 (A), side-treated IG2 (B) and IG2 (C) nets. Black represents IG2 net panels and light grey represents untreated net panels
Fig. 2Mortality of wild free-flying An. arabiensis at 24, 48 and 72 h in trial arms. Error bars represent 95% confidence interval. Confidence intervals for 0% mortality are one sided
Outcomes adjusted for random effects due to cows, huts, trial Latin square rotation and trial night
| Outcome | Untreated | Roof-treated IG2 | Side treated IG2 | IG2 |
|---|---|---|---|---|
| % Mortality at 72 h (95% CI) | 1.2a (0.0–3.9) | 27.4b (10.6–38.2) | 44.4bc (30.9–57.8) | 53.3c (39.1–67.5) |
| % killing effect (95% CI) | – | 24.8 (17.1–33.8) | 26.5 (18.7–35.7) | 37.2 (28.3–46.8) |
| % Blood fed (95% CI) | 21.9a (9.6–34.2) | 10.5a (3.0–18.1) | 13.7a (4.3–23.0) | 18.8a (7.6–30.1) |
| % Blood feeding inhibition | – | 52.0 | 37.4 | 14.1 |
| % Exiting (95% CI) | 92.5a (82.5–100) | 89.4a (77.5–100) | 97.1a (91.2–100) | 94.4a (86.4–100) |
| Predicated mean catches (95% CI) | 1.3a (0.8–1.7) | 1.7a (1.1–2.4) | 1.2a (0.7–1.7) | 1.4a (0.9–2.0) |
Treatments sharing the same letter script in each row do not differ significantly (P > 0.05, OR = 1 or rate ratio = 1)